2014 annual financial data

GT Biopharma 2014 Operating margin

GT Biopharma 2014 operating margin with verified reported values.

Direct answer

Operating margin was -3,927.87%.

Operating income was -2,396,000 USD and net income was -23,489,000 USD.
Operating cash flow was -1,749,000 USD.

Get free GT Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
61,000 USD
Operating income
-2,396,000 USD
Net income
-23,489,000 USD
Operating cash flow
-1,749,000 USD